Cocern Around Oxford-AstraZeneca COVID-19 Vaccine
With the race to vaccinate the population the 2021 goal, questions of safety have come to the public’s attention. The Oxford-AstraZeneca vaccine has received some doubts surrounding blood clots.
Joined us today is Professor Robert Booy. Robert is a Senior Professorial Fellow at the University of Sydney Children’s Hospital Westmead Clinical School and he also held the position of Head of Clinical Research at the National Centre for Immunisation Research and Surveillance (NCIRS) from 2005-2019.